Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001628280-20-017844
Filing Date
2020-12-30
Accepted
2020-12-30 17:30:20
Documents
3
Period of Report
2020-12-30

Document Format Files

Seq Description Document Type Size
1 6-K a6kmcrotsuka-aurinia.htm 6-K 14278
2 EX-99.1 ex991-mcrotsukaxaurinia.htm EX-99.1 17372
3 EX-99.2 ex992otsuka-auriniacollabo.htm EX-99.2 925572
  Complete submission text file 0001628280-20-017844.txt   958220
Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

EIN.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36421 | Film No.: 201426852
SIC: 2834 Pharmaceutical Preparations